These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7891324)

  • 1. Effects of specific antibody Fab fragments on desipramine pharmacokinetics in the rat in vivo and in the isolated, perfused liver.
    Keyler DE; Le Couteur DG; Pond SM; St Peter JV; Pentel PR
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1117-23. PubMed ID: 7891324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of desipramine toxicity in rats using drug-specific antibody Fab' fragment: effects on hypotension and interaction with sodium bicarbonate.
    Brunn GJ; Keyler DE; Pond SM; Pentel PR
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1392-9. PubMed ID: 1312169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of desipramine toxicity in rats with polyclonal drug-specific antibody Fab fragments.
    Pentel PR; Ross CA; Landon J; Sidki A; Shelver WL; Keyler DE
    J Lab Clin Med; 1994 Mar; 123(3):387-93. PubMed ID: 8133150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments.
    Ochs HR; Smith TW
    J Clin Invest; 1977 Dec; 60(6):1303-13. PubMed ID: 914999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and toxicity of high doses of antibody Fab fragments in rats.
    Pentel PR; Keyler DE; Gilbertson DG; Ruth G; Pond SM
    Drug Metab Dispos; 1988; 16(1):141-5. PubMed ID: 2894943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colchicine-specific Fab fragments alter colchicine disposition in rabbits.
    Sabouraud AE; Urtizberea M; Cano NJ; Grandgeorge M; Rouzioux JM; Scherrmann JM
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1214-9. PubMed ID: 1545388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship.
    Pentel PR; Keyler DE; Brunn GJ; Milavetz JM; Gilbertson DG; Matta SG; Pond SM
    Drug Metab Dispos; 1991; 19(1):24-8. PubMed ID: 1673407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of a monoclonal anti-phencyclidine Fab fragment of immunoglobulin G in rats.
    McClurkan MB; Valentine JL; Arnold L; Owens SM
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1439-45. PubMed ID: 8371148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of recombinant drug-specific single chain antibody Fv fragment on [3H]-desipramine distribution in rats.
    Shelver WL; Keyler DE; Lin G; Murtaugh MP; Flickinger MC; Ross CA; Pentel PR
    Biochem Pharmacol; 1996 Feb; 51(4):531-7. PubMed ID: 8619899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic disposition and toxicity of cationized goat immunoglobulin G and fab fragments in isolated perfused rat liver.
    Hong G; Bazin-Redureau M; Gires P; Scherrmann JM
    Drug Metab Dispos; 1998 Jul; 26(7):661-9. PubMed ID: 9660848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of colchicine-specific Fab fragments on the hepatic clearance of colchicine.
    Sabouraud A; Redureau M; Gires P; Martinet M; Scherrmann JM
    Drug Metab Dispos; 1993; 21(6):997-1002. PubMed ID: 7905405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin G, F(AB')2, and fab fragment uptake kinetics in isolated perfused rat liver and rat hepatic cells.
    Bazin-Redureau M; Gires P; Chapelle P; Martinet M; Scherrmann JM
    Drug Metab Dispos; 1995 Dec; 23(12):1400-6. PubMed ID: 8689951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-phencyclidine monoclonal Fab fragments markedly alter phencyclidine pharmacokinetics in rats.
    Valentine JL; Arnold LW; Owens SM
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1079-85. PubMed ID: 8014850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of high dose alpha-1-acid glycoprotein on desipramine toxicity in rats.
    Pentel PR; Keyler DE
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1061-6. PubMed ID: 3418509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tricyclic antidepressant-specific Fab fragments alter the distribution and elimination of desipramine in the rabbit: a model for overdose treatment.
    Hursting MJ; Opheim KE; Raisys VA; Kenny MA; Metzger G
    J Toxicol Clin Toxicol; 1989; 27(1-2):53-66. PubMed ID: 2769821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats.
    Valentine JL; Owens SM
    J Pharmacol Exp Ther; 1996 Aug; 278(2):717-24. PubMed ID: 8768723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phencyclidine-specific Fab fragments alter phencyclidine disposition in dogs.
    Owens SM; Mayersohn M
    Drug Metab Dispos; 1986; 14(1):52-8. PubMed ID: 2868866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of high doses of polyclonal drug-specific antibody Fab fragments.
    Keyler DE; Shelver WL; Landon J; Sidki A; Pentel PR
    Int J Immunopharmacol; 1994 Dec; 16(12):1027-34. PubMed ID: 7705964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.